The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and α1-blockers-Reference-Cited by-同舟云学术

The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and α1-blockers

Published:2001-03 Issue:Supplement Volume:19 Page:575-582
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:Journal of Hypertension

Author:

Ohtahara Akira,Hisatome Ichiro,Yamamoto Yasutaka,Furuse Masako,Sonoyama Kazuhiko,Furuse Yoshiyuki,Hamada Toshihiro,Katoh Masahiko,Watanabe Masashi,Kinugawa Toru,Ogino Kazuhide,Igawa Osamu,Shimomura Tokio,Murakami Fumiyo,Yamamoto Tetsuya,Shigemasa Chiaki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference47 articles.

1. Does treatment-mediated increase in uric acid reduce the cardioprotective effect of diuretics in hypertensive patients?

2. Relation of Serum Uric Acid to Mortality and Ischemic Heart Disease

3. Uric acid as an independent risk factor in the treatment of hypertension

4. Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cilnidipine and magnesium sulfate supplement ameliorates hyperglycemia, dyslipidemia and inhibits oxidative-stress in fructose-induced diabetic rats;Heliyon;2022-01

2. Hyperuricemia as a Risk Factor for Cardiovascular Diseases;Journal of Biomedicine and Translational Research;2020-12-23

3. The effectiveness of military physical exercise on irisin concentrations and oxidative stress among male healthy volunteers;Hormone Molecular Biology and Clinical Investigation;2020-05-07

4. Influence of dietary inorganic nitrate on blood pressure and vascular function in hypertension: prospective implications for adjunctive treatment;Journal of Applied Physiology;2019-10-01

5. Effects of Irbesartan on Uric Acid Metabolism in Patients with Treated Essential Hypertension;Vascular Failure;2018-03-31